Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

Europe - OSL:BNOR - NO0010379266 - Common Stock

463.5 NOK
+4 (+0.87%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

4

BNOR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 62 industry peers in the Oil, Gas & Consumable Fuels industry. There are concerns on the financial health of BNOR while its profitability can be described as average. BNOR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BNOR had negative earnings in the past year.
In the past year BNOR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BNOR reported negative net income in multiple years.
In the past 5 years BNOR always reported a positive cash flow from operatings.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BNOR has a Return On Assets of -0.78%. This is in the lower half of the industry: BNOR underperforms 79.03% of its industry peers.
BNOR has a Return On Equity of -3.62%. This is in the lower half of the industry: BNOR underperforms 79.03% of its industry peers.
BNOR has a Return On Invested Capital (5.61%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BNOR is in line with the industry average of 9.92%.
Industry RankSector Rank
ROA -0.78%
ROE -3.62%
ROIC 5.61%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

BNOR has a better Operating Margin (28.10%) than 66.13% of its industry peers.
In the last couple of years the Operating Margin of BNOR has grown nicely.
BNOR has a better Gross Margin (56.91%) than 69.35% of its industry peers.
In the last couple of years the Gross Margin of BNOR has grown nicely.
Industry RankSector Rank
OM 28.1%
PM (TTM) N/A
GM 56.91%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

2

2. Health

2.1 Basic Checks

BNOR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BNOR has been increased compared to 1 year ago.
BNOR has more shares outstanding than it did 5 years ago.
BNOR has a worse debt/assets ratio than last year.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of BNOR is 9.10, which is on the high side as it means it would take BNOR, 9.10 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.10, BNOR perfoms like the industry average, outperforming 43.55% of the companies in the same industry.
BNOR has a Debt/Equity ratio of 1.50. This is a high value indicating a heavy dependency on external financing.
BNOR has a Debt to Equity ratio of 1.50. This is amonst the worse of the industry: BNOR underperforms 83.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 9.1
Altman-Z N/A
ROIC/WACC0.67
WACC8.37%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

BNOR has a Current Ratio of 1.41. This is a normal value and indicates that BNOR is financially healthy and should not expect problems in meeting its short term obligations.
BNOR has a Current ratio of 1.41. This is comparable to the rest of the industry: BNOR outperforms 56.45% of its industry peers.
A Quick Ratio of 1.27 indicates that BNOR should not have too much problems paying its short term obligations.
BNOR has a better Quick ratio (1.27) than 62.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.27
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for BNOR have decreased strongly by -560.00% in the last year.
BNOR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.88%.
BNOR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.10% yearly.
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%52.34%

3.2 Future

The Earnings Per Share is expected to grow by 30.91% on average over the next years. This is a very strong growth
Based on estimates for the next years, BNOR will show a quite strong growth in Revenue. The Revenue will grow by 8.69% on average per year.
EPS Next Y259.6%
EPS Next 2Y114.69%
EPS Next 3Y61.32%
EPS Next 5Y30.91%
Revenue Next Year46.12%
Revenue Next 2Y31.15%
Revenue Next 3Y17.93%
Revenue Next 5Y8.69%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -100 -200 -300

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNOR. In the last year negative earnings were reported.
BNOR is valuated cheaply with a Price/Forward Earnings ratio of 6.42.
88.71% of the companies in the same industry are more expensive than BNOR, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, BNOR is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.42
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BNOR is on the same level as its industry peers.
BNOR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BNOR is cheaper than 82.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.62
EV/EBITDA 5.56
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

BNOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BNOR's earnings are expected to grow with 61.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y114.69%
EPS Next 3Y61.32%

0

5. Dividend

5.1 Amount

No dividends for BNOR!.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (10/3/2025, 7:00:00 PM)

463.5

+4 (+0.87%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-10 2025-07-10/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners39.26%
Inst Owner ChangeN/A
Ins Owners1.13%
Ins Owner ChangeN/A
Market Cap12.28B
Analysts78.57
Price Target579.7 (25.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-62.89%
Min EPS beat(2)-71.31%
Max EPS beat(2)-54.48%
EPS beat(4)0
Avg EPS beat(4)-147.45%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)0
Avg EPS beat(8)-120.71%
EPS beat(12)3
Avg EPS beat(12)-79.82%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.71%
Min Revenue beat(2)-33.43%
Max Revenue beat(2)-1.98%
Revenue beat(4)0
Avg Revenue beat(4)-14.09%
Min Revenue beat(4)-33.43%
Max Revenue beat(4)-1.98%
Revenue beat(8)2
Avg Revenue beat(8)-7.17%
Revenue beat(12)4
Avg Revenue beat(12)-4.24%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.58%
PT rev (3m)-20.62%
EPS NQ rev (1m)-17.17%
EPS NQ rev (3m)-40.64%
EPS NY rev (1m)-24.61%
EPS NY rev (3m)-47.3%
Revenue NQ rev (1m)-7.55%
Revenue NQ rev (3m)-10.84%
Revenue NY rev (1m)-2.36%
Revenue NY rev (3m)-19.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.42
P/S 1.55
P/FCF 7.62
P/OCF 4.03
P/B 1.62
P/tB 1.98
EV/EBITDA 5.56
EPS(TTM)-13.73
EYN/A
EPS(NY)72.17
Fwd EY15.57%
FCF(TTM)60.86
FCFY13.13%
OCF(TTM)114.89
OCFY24.79%
SpS298.25
BVpS286.99
TBVpS234.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.78%
ROE -3.62%
ROCE 7.28%
ROIC 5.61%
ROICexc 6.57%
ROICexgc 6.94%
OM 28.1%
PM (TTM) N/A
GM 56.91%
FCFM 20.41%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexcg growth 3Y15.21%
ROICexcg growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 1.5
Debt/FCF 9.1
Debt/EBITDA 2.81
Cap/Depr 78.38%
Cap/Sales 18.11%
Interest Coverage 1.94
Cash Conversion 75.22%
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.27
Altman-Z N/A
F-Score5
WACC8.37%
ROIC/WACC0.67
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-560%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%800%
EPS Next Y259.6%
EPS Next 2Y114.69%
EPS Next 3Y61.32%
EPS Next 5Y30.91%
Revenue 1Y (TTM)9.88%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%52.34%
Revenue Next Year46.12%
Revenue Next 2Y31.15%
Revenue Next 3Y17.93%
Revenue Next 5Y8.69%
EBIT growth 1Y-10.29%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year195.77%
EBIT Next 3Y50.93%
EBIT Next 5Y23.2%
FCF growth 1Y-30.87%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y-39.47%
OCF growth 3Y84.65%
OCF growth 5Y4.46%